General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-09 | 2024-03 | -0.09 | -0.09 | -0.01 | -5.88% |
2024-03-14 | 2023-12 | -0.05 | N/A | N/A | N/A |
2023-11-08 | 2023-09 | -0.09 | -0.08 | 0.01 | 11.11% |
2023-08-25 | 2023-06 | -0.03 | -0.06 | -0.03 | -100.00% |
2023-05-08 | 2023-03 | -0.15 | -0.14 | 0.01 | 6.67% |
2023-03-09 | 2022-12 | -0.14 | -0.04 | 0.1 | 71.43% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-26 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-27 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
2023-08-10 | HC Wainwright & Co. | Upgrade | Neutral | Neutral |
2023-06-20 | HC Wainwright & Co. | Upgrade | Neutral | Neutral |
2023-06-13 | HC Wainwright & Co. | Upgrade | Neutral | Neutral |
2023-06-01 | HC Wainwright & Co. | Upgrade | Neutral | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-06-05 | ADAMS ADRIAN | Director | 134.80K | Stock Award(Grant) |
2024-02-28 | BURKE STEVEN KEITH | Officer | 695.84K | Sale |
2024-02-28 | BUTLER JOHN P | Chief Executive Officer | 2.36M | Sale |
2024-02-28 | DAHAN MICHEL | Chief Operating Officer | 706.93K | Sale |
2024-01-30 | GRUND NICHOLAS | Officer | 303.30K | Stock Award(Grant) |
2024-02-28 | HADAS NICOLE R | Officer | 663.26K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Alerce Investment Management, L.P. | 16.21M | 14.83M | 8.61% |
2023-06-29 | Vanguard Group Inc | 7.81M | 7.15M | 4.15% |
2023-06-29 | Acadian Asset Management. LLC | 7.46M | 6.83M | 3.96% |
2023-06-29 | Renaissance Technologies, LLC | 3.33M | 3.05M | 1.77% |
2023-06-29 | Blackrock Inc. | 2.74M | 2.50M | 1.45% |
2023-06-29 | Millennium Management Llc | 2.01M | 1.84M | 1.07% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 4.07M | 3.72M | 2.16% |
2023-06-29 | Vanguard Extended Market Index Fund | 2.60M | 2.38M | 1.38% |
2023-07-30 | USAA Mutual Fund Tr-Science & Technology Fund | 2.02M | 3.37M | 1.07% |
2023-05-30 | Fidelity Extended Market Index Fund | 942.20K | 979.89K | 0.50% |
2023-07-30 | Federated Hermes MDT Mid Cap Growth Fund | 908.35K | 1.52M | 0.48% |
2023-06-29 | Victory Portfolios-Victory RS Science & Technology Fund | 423.29K | 387.31K | 0.22% |
This is wild…nothing makes any sense
Garcia Lorca can suck a fat d**k! Bye
$AKBA FDA Approval will lead to higher highs!!!
$AKBA should trade higher… but nice price to get in…
$AKBA engaged new employees… sounds good!!
What BS is going on? Down $2K already
What makes everyone think there’s a BO??
Strong buy imo..I’ll keep loading up sub 2
$AKBA Out of this crap. It will further go down AH, might get in again
Out ofthi
Investorplace_personal it looks like you have a problem, i guess that means you have a huge short position. Congatulations!! Eat a bag of d ic. I hope you lose everything. BO iminent
HALT INCOMING